Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by ARIMA11on Nov 17, 2021 2:20pm
343 Views
Post# 34137360

Interesting

Interestinghttps://www.wsj.com/articles/ge-pounces-on-surging-healthcare-demand-with-spinoff-11637077092?

The global market for equipment for medical imaging—including ultrasounds, MRIs, X-rays and CT scans—was worth around $22 billion in sales globally in 2020, according to healthcare technology data provider Signify Research. The figure doesn’t include software and services, a highly profitable add-on.
 
GE’s healthcare unit is the world leader in the medical-imaging equipment market with a share of around 26%, closely followed by Siemens Healthineers with 21% and Philips with 17%, Signify Research said. The GE division, which has more than four million installed units world-wide, generated about $18 billion in revenue last year.
 
In June, GE named Peter Arduini to lead the division, effective in January. Mr. Arduini joins the company after a stint as the CEO of Integra LifeSciences, a maker of surgical instruments and other medical products. Mr. Arduini’s record at Integra suggests he might look to shed products and businesses that aren’t core to GE Healthcare, while pursuing acquisitions to build up more promising divisions, Wells Fargo analyst Larry Biegelsen said in a research note.
 
Globally, more than 200 startups are developing medical imaging AI applications, according to Signify Research.
 
“Amongst startups in the AI space the competition is intense,” Mr. Abrams said. “GE would have to develop these technologies themselves or purchase those upstarts.”
<< Previous
Bullboard Posts
Next >>